Anonymous ID: eadeea April 6, 2022, 5:30 p.m. No.16026294   🗄️.is 🔗kun   >>6303 >>6473 >>6663 >>6713 >>6808 >>6960

Tings be habbening in the legislatures on early treatment prescribing. Is gud. Is late but gud.

26 states doing it.

 

https://track.govhawk.com/reports/2lWe3/public

 

Sample.

 

Alaska

BILL

Session: 32nd Legislature

Jurisdiction: AK

Bill Number: HB 383

Bill Title: An Act removing ivermectin and hydroxychloroquine from the definition of prescription drugs.

Sponsor: Christopher Kurka

Introduced Date: 02/22/2022

Note :

 

Summary: Removes ivermectin and hydroxychloroquine from the list of prescription drugs, making them available for purchase over the counter.

Status:

Last Action: Bill Created - (02/22/2022)

Last Action Date: 02/22/2022

Session: 32nd Legislature

Jurisdiction: AK

Bill Number: HB 380

Bill Title: An Act relating to the prescription and dispensation of ivermectin.

Sponsor: David Eastman

Introduced Date: 02/22/2022

Note :

 

Summary: Allows physicians or chief medical officers to prescribe ivermectin by standing order, and prohibits "actions" taken against either for damages resulting from a good faith standing order prescription. Pharmacists may dispense according to the standing order, provide the patient with an information that may not discourage using ivermectin for the treating Covid-19. Pharmacists are also immune from "actions" resulting from a good faith dispensing.

 

Alabama

BILL

Session: 2022 Regular Session

Jurisdiction: AL

Bill Number: HB 510

Bill Title: COVID-19, occupational licensing boards prohibited to take adverse action based on physician's recommended COVID-19 treatment, health care facilities and

Sponsor: Arnold G. Mooney II

Introduced Date: 03/17/2022

Note :

 

Summary: Prohibits occupational licensing boards from taking adverse action against a physician who recommends a COVID-19 treatment that is not FDA-approved, requires patient's written informed consent to receive a non-FDA approved treatment, pharmacies to fulfill prescriptions that are not FDA-approved to treat COVID, and health care facilities to provide a patient's requested off-label use COVID-19 treatment. The bill also allows licensees to bring civil actions against a licensing board if they are subject to disciplinary actions, patients to bring civil actions against pharmacies for violating the bill's terms, and gives licensing boards and pharmacists civil immunity resulting from a patient's use of a recommended or prescribed treatment for COVID-19.